1050 Participants NeededMy employer runs this trial

Educational Intervention for Low Health Literacy in Surgery

KH
DI
Overseen ByDaniel I Chu, MD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Alabama at Birmingham
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

Low health literacy patients are a vulnerable population at high-risk for surgical disparities including longer hospital stays, more complications, and more readmissions. This study will adapt enhanced recovery programs (ERPs) to low health literacy patients with a multilevel, health literacy-based implementation strategy (called VISACT - VISuAl aids, Coach providers in communication, and Train organizations in health literacy) to improve ERP fidelity and thereby outcomes. In the final aim of this project (Specific Aim 3), the VISACT intervention will be tested in a pilot trial. Findings from this study will lay the foundation for a multi-institutional stepped-wedge trial and establish key principles for adapting interventions to eliminate disparities.

Who Is on the Research Team?

DI

Daniel I Chu, MD

Principal Investigator

University of Alabama at Birmingham

Are You a Good Fit for This Trial?

This trial is for English-speaking adults of any gender or race who are able to give consent and have low health literacy, especially those undergoing surgery for colorectal disorders.

Inclusion Criteria

I speak English.
My race/ethnicity does not affect my eligibility.
I can understand and agree to the study's requirements.
See 1 more

What Are the Treatments Tested in This Trial?

Interventions

  • VISACT (VISuAl aids, Coach providers in communication, and Train organizations in health literacy)

Trial Overview

The study is testing an educational program called VISACT, which uses visual aids, trains healthcare providers in better communication, and helps organizations support patients with low health literacy during surgical recovery.

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: Pre-Post ArmExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Alabama at Birmingham

Lead Sponsor

Trials
1,677
Recruited
2,458,000+

National Cancer Institute (NCI)

Collaborator

Trials
14,080
Recruited
41,180,000+